Skip to content
Biodatica
Start free

Investigator

John D. Heintzman

OCHIN, INC. · funded by NCI, NHLBI

Companies
2

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.5M

Summed across those awards.

First award
May 20, 2022

Latest Sep 23, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Healthcare utilization and outcomes across the cancer care continuum: Understanding the impact of social risk factors and screening among Latino patients

    $649k

    Sep 23, 2025NCIOCHIN, INC.NIH RePORTER · 11241042 (opens the source filing in a new tab)

  2. R01

    EQUITABLE: Equity in Treatment for Asthma Between Latinos and Whites

    $674k

    Mar 1, 2025NHLBIOCHIN, INC.NIH RePORTER · 11044352 (opens the source filing in a new tab)

  3. R01

    Quality and effective care for Latino adults with asthma in community health centers

    $650k

    Mar 1, 2025NHLBIOCHIN, INC.NIH RePORTER · 11294202 (opens the source filing in a new tab)

  4. R01

    FRONTIERS: Foreign-Born Latinos Cancer Screening

    $563k

    May 20, 2022NCIOREGON HEALTH & SCIENCE UNIVERSITYNIH RePORTER · 11074643 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources